GEORGE STOKES: Open Payments
NPI 1003824509 · CLEVELAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,708 in 67 payments from 20 companies in 2025. Trend: 2023 $1,425 · 2024 $1,540 · 2025 $1,708
Food & beverage: $1,609Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $421 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $183 |
| Corcept Therapeutics | 7 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $145 |
| Novo Nordisk Inc | 7 | $140 |
| GlaxoSmithKline, LLC. | 6 | $135 |
| Inspire Medical Systems, Inc. | 2 | $111 |
| Astellas Pharma US Inc | 1 | $99 |
| Antares Pharma, Inc. | 3 | $55 |
| Viatris Specialty LLC | 2 | $46 |
Products named: AIRSUPRA, Kerendia, Korlym, XIFAXAN, BREZTRI, INSPIRE, TRELEGY ELLIPTA, Ozempic.
Industry payments across TX — which companies pay providers there.
